Wuxi Pharmatech (cayman) Inc. - Net Worth and Insider Trading

Wuxi Pharmatech (cayman) Inc. Net Worth

The estimated net worth of Wuxi Pharmatech (cayman) Inc. is at least $6.8 Billion dollars as of 2024-06-22. Wuxi Pharmatech (cayman) Inc. is the 2201 Interest of corporation controlled by you of WuXi Biologics (Cayman) Inc and owns about 584,191,133 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) stock worth over $6.8 Billion. Details can be seen in Wuxi Pharmatech (cayman) Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wuxi Pharmatech (cayman) Inc. has not made any transactions after 2023-01-19 and currently still holds the listed stock(s).

Transaction Summary of Wuxi Pharmatech (cayman) Inc.

To

Wuxi Pharmatech (cayman) Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wuxi Pharmatech (cayman) Inc. owns 1 companies in total, including WuXi Biologics (Cayman) Inc (HKSE:02269) .

Click here to see the complete history of Wuxi Pharmatech (cayman) Inc.’s form 4 insider trades.

Insider Ownership Summary of Wuxi Pharmatech (cayman) Inc.

Ticker Comapny Transaction Date Type of Owner
HKSE:02269 WuXi Biologics (Cayman) Inc 2023-01-19 2201 Interest of corporation controlled by you

Wuxi Pharmatech (cayman) Inc. Latest Holdings Summary

Wuxi Pharmatech (cayman) Inc. currently owns a total of 1 stock. Wuxi Pharmatech (cayman) Inc. owns 584,191,133 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) as of January 19, 2023, with a value of $6.8 Billion.

Latest Holdings of Wuxi Pharmatech (cayman) Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02269 WuXi Biologics (Cayman) Inc 2023-01-19 584,191,133 11.60 6,776,617,143

Holding Weightings of Wuxi Pharmatech (cayman) Inc.


Wuxi Pharmatech (cayman) Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Wuxi Pharmatech (cayman) Inc. has made a total of 2 transactions in WuXi Biologics (Cayman) Inc (HKSE:02269) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in WuXi Biologics (Cayman) Inc is the sale of 56,000,000 shares on January 19, 2023, which brought Wuxi Pharmatech (cayman) Inc. around $0.

Insider Trading History of Wuxi Pharmatech (cayman) Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wuxi Pharmatech (cayman) Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wuxi Pharmatech (cayman) Inc. Ownership Network

Ownership Network List of Wuxi Pharmatech (cayman) Inc.

No Data

Ownership Network Relation of Wuxi Pharmatech (cayman) Inc.

Insider Network Chart

Wuxi Pharmatech (cayman) Inc. Owned Company Details

What does WuXi Biologics (Cayman) Inc do?

Who are the key executives at WuXi Biologics (Cayman) Inc?

Wuxi Pharmatech (cayman) Inc. is the 2201 Interest of corporation controlled by you of WuXi Biologics (Cayman) Inc. Other key executives at WuXi Biologics (Cayman) Inc include 2201 Interest of corporation controlled by you BlackRock, Inc. , 2201 Interest of corporation controlled by you Jpmorgan Chase & Co. , and 2201 Interest of corporation controlled by you Li Ge .

WuXi Biologics (Cayman) Inc (HKSE:02269) Insider Trades Summary

Over the past 18 months, Wuxi Pharmatech (cayman) Inc. made 1 insider transaction in WuXi Biologics (Cayman) Inc (HKSE:02269) with a net sale of 56,000,000. Other recent insider transactions involving WuXi Biologics (Cayman) Inc (HKSE:02269) include a net purchase of 103,747,521 shares made by Jpmorgan Chase & Co. , a net sale of 0 shares made by BlackRock, Inc. , and a net sale of 0 shares made by Citigroup Inc. .

In summary, during the past 3 months, insiders sold 0 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) in total and bought 39,637,531 shares, with a net purchase of 39,637,531 shares. During the past 18 months, 406,720,548 shares of WuXi Biologics (Cayman) Inc (HKSE:02269) were sold and 179,274,569 shares were bought by its insiders, resulting in a net sale of 227,445,979 shares.

WuXi Biologics (Cayman) Inc (HKSE:02269)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

WuXi Biologics (Cayman) Inc Insider Transactions

No Available Data

Wuxi Pharmatech (cayman) Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Wuxi Pharmatech (cayman) Inc.. Currently GuruFocus does not have mailing address information for Wuxi Pharmatech (cayman) Inc..

Discussions on Wuxi Pharmatech (cayman) Inc.

No discussions yet.